Member Info for EmeraldCarrots

Any serious bid would double the sp in minutes IMHO.

Fevertreeman

2Offered at 11p...down 15% in 2 weeks, and 27% since Newland's cash raise.....the Newland discount in full view2.

=================================================

Clearly Newland has not managed to land another Astrazeneca of Eisai contract, yet. No doubt some who post here would comment "he never will" of some such negative. Do they really believe that, of course not. The lack of news has given the negative posters a boost. But lack of "big RNS news" does not necessarily mean the interim results will be bad.

The new CellKeep slide is an integral part of ANGLE's Portrait®+ CTC staining kit which is available for customers to identify and enumerate CTCs harvested using the Parsortix system. I was watching the video again and this kit (has 10 per box) is £3,000 per box. Then I remembered the machines themselves cost North of £50,000.

- I think people should not be so sure the results won't be good as some are plastering the whole web with. The placing price was 15p a share back in June. The sp is already 30% lower. A very bad update is already "built in" if you ask me.

https://www.youtube.com/watch?v=hxu_XmeIpDA

All IMHO.

Rewards. It is inconceivable they won't have good sales in the NHS and rest of the World now the NHS has tested and cleared the two machines for use in the NHS. That will spur on sales to other countries.

Wait and win IMHO.

All IMHO.

Going down!

Astaris Capital Management LLP 1.80% 13 Sep 2024

Astaris Capital Management LLP 1.93% 12 Sep 2024

Astaris Capital Management LLP 2.05% 11 Sep 2024

Astaris Capital Management LLP 2.12% 10 Sep 2024

Astaris Capital Management LLP 2.35% 6 Sep 2024

Astaris Capital Management LLP 2.48% 5 Sep 2024

Up 7.6%. Smell shorters blood???????

Maybe the larger shorting Co's have decided to take their profits. Risk/reward too high now?

Certainly an interesting situation here. The sp fall from about 75p a share down to what......, 10.6p (I bought some at 10.6p). So now up to 17.1/17.2p with the major shorting Co's resucing their positions almost daily. Will end in joy or tears I think!

Up 3.2%.

Up 8.56%. Much further and the "bid" and takeover rumours will start IMHO. Happy days!

Maxdba.

I agree. Most of the Companies shorting PFC must be still up a shed load. All the ones that the short tracker site report have been reducing their positions. Pressure to take profit must be huge. Hold, and if a bid comes it they could get slaughtered.

All IMHO.

Up 5.89%.

Shorting Co's seem to be running for the exit......

Is this:- "Patients with HER2-negative primary tumours, but HER2-positive CTCs, who received lapatinib in the DETECT III trial, showed improved overall survival compared with those who did not receive the targeted therapy.

Our HER2 assay can help identify individuals with HER2-positive CTCs and prior HER2-negative primary tumours, ****and may assist in identifying those who could benefit from HER2-targeted treatments within a clinical trial.****". This is what the Eisai contract is all about. Good that the assay became available (see web site) before this massive ESMO conference which is on now - 13th to 17th Sept.

https://angleplc.com/laboratory-services/her2/

Started last Friday and ends this Tuesday.

Main Sponsors

Bayer Healthcare, Beigene, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo

, Eisa, Gilead - Kite, GSK logo, Illumina, Ipsen, Johnson & Johnson, Lilly, MSD, novocure-logo, Pfizer, Thermofisher.

Participants:-

https://www.esmo.org/meeting-calendar/esmo-congress-2024/industry-participation

https://www.esmo.org/about-esmo

PD101.

"Interest returning here".

==========================

About time. A few got in sub 11p, ask now 11.5p.

If it manages to finish up again. Will see.

Researcher1.

Your post (below), says "until Newland accepts he's a serial liar". I pointed this out earlier as calling some one a serial liar is against the law in the UK, unless you can prove it I suppose. Now THAT post has been deleted by LSE........... LOL!!! What can one say! This is what your post says:-

================

Less of the squabbling please children, it doesn't help. I can't pretend I'm not expecting a huge miss on revenue, which will send the SP to new lows. Then, and only then, and depending on fundraising plans, there may just be a long term Buy argument, but I don't think I will until Newland accepts ***he's a serial liar*** (he would say 'misjudger') and hands over the tiller.

=================

Maybe LSE just want to leave it as it is. I mean, who cares if it is unlawful.

"Good to be back..oh still looks f@@ked bye!"

=====================

TwoGood2Die. That is so informative of you. Sort of thing LSE loves I think.

I'll post no opinion same as you do every time you do rude and meaningless posts.

TGTD said,

🥕 why do you feel the need to keep copying and posting the same stuff that's months old if not years over and over again!

===========================

Have a guess.

It's 3.75% up now and let's face it that is unusual. Down later........................... or is this the turning point? Director bought 1m shares @ 3.1p on 15th Sept costing £31,000....